Colorcon News and Updates from The Economic Times

Searched for

COLORCON

Dividend given to non-residents can’t be taxed at rates higher than DTAA, rules Bombay High Court; Know what it means for NRIs
Pharma co Ideal Cures’ founder Suresh Pareek buys Rs 64-crore luxury pad in Mumbai’s Worli
Colorcon buys TA-backed pharma firm Ideal Cures

- Govt may review disinvestment norms
  Last Month, FIPB Rejected Pharma Co Colorcon’s Plea To Waive Mandatory Dilution Of Shareholding To 74% In Indian Venture.
  01 Aug, 2007, 02.20 AM IST
Load More